Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
Condition(s):Pneumonia, BacterialLast Updated:March 26, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Pneumonia, BacterialLast Updated:March 26, 2024Recruiting
Condition(s):Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial PneumoniaLast Updated:March 8, 2023Recruiting
Condition(s):Community-acquired Pneumonia; Bacterial PneumoniaLast Updated:March 8, 2024Recruiting
Condition(s):Pneumonia; Pneumonia, Viral; Pneumonia, BacterialLast Updated:February 20, 2024Recruiting
Condition(s):Community-acquired Bacterial PneumoniaLast Updated:December 8, 2023Recruiting
Condition(s):Pneumonia, BacterialLast Updated:February 20, 2024Not yet recruiting
Condition(s):Gram-negative Bacterial Infections; Hospital Acquired Bacterial Pneumonia (HABP); Complicated Urinary Tract Infection (cUTI); Ventilator Associated Bacterial Pneumonia (VABP)Last Updated:January 24, 2024Recruiting
Condition(s):Pneumonia, BacterialLast Updated:July 5, 2019Recruiting
Condition(s):Hospital-acquired Bacterial Pneumonia; Ventilator-associated Bacterial PneumoniaLast Updated:October 17, 2023Not yet recruiting
Condition(s):Pneumonia, Bacterial; Ventilator Associated PneumoniaLast Updated:February 20, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.